Nordex SE NDX1.DE
Composite 61/100; the shares have moved about 42% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 41/100 — a slight mark against it.
Growth ranks 88/100 — a strong point in its favour. Balance-sheet strength ranks 68/100 — a moderate point in its favour. Quality ranks 56/100 — a slight point in its favour.
Momentum ranks 41/100 — a slight mark against it.
What the company does Nordex SE designs, manufactures, and services multi-megawatt onshore wind turbines globally, operating via Projects and Services segments. Its Delta4000 and Delta platforms target utility-scale wind farms, with offerings spanning project development, maintenance, upgrades, and efficiency enhancements.
Key financials Nordex reports strong profitability metrics: ROE 27.5%, ROA 6.0%, and ROCE 20.3%. Margins stand at gross 26.9%, operating 5.6%, and net 4.2%, with revenue growth of 10.6% and EPS growth of 633.3%. Debt/Equity is 0.34 and net debt/EBITDA is -1.84, indicating a net cash position.
Stock health The stock shows mixed momentum: -21.10% over 3 months but +82.29% over 12 months, with a current RSI(14) of 38.80. Quality metrics are solid (Piotroski F-Score 8/9, Altman Z 2.47), though Valuation and Income scores are average at 49.8 and 50.0, respectively.
Price vs fair value Nordex trades at a PREMIUM of 62.40% to our fair-value estimate of 14.41 and at a discount of 25.11% to the analyst 12-month target of 47.89. - Strong Q2 2026 EBITDA growth and 2026 outlook confirmation (Oilprice.com) - Robust revenue growth and order intake highlighted in Q2 earnings call (GuruFocus.com) - Analyst count of 15.0 supports the 47.89 target (analyst count 15.0)
Looking forward Forward P/E of 39.84 and EV/EBITDA of 15.33 reflect elevated expectations, while Growth score of 84.3 underscores optimism. Execution on order backlog and margin stability will be key to justifying current valuations.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.